In order to study the correlation between riskscores and clinical characteristics, we further analyzed the high-risk and low-risk groups and clinical characteristics including age, tumor subtypes, ER, PR, HER2 expression levels, stage status and TNM status. This evidence concerns the gene ERBB2 and neoplasm.